Deutsche Bank’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Deutsche Bank’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-99	Closed	-$11K	–	5197
2019 Q3	$11K	Buy	+99	New	+$19.9K	﹤0.01%	4486
2018 Q4	–	Sell	-12	Closed	-$11K	–	5520
2018 Q3	$11K	Sell	12 -40	-77%	-$26.4K	﹤0.01%	5066
2018 Q2	$31K	Buy	52 +51	+5,100%	+$33.3K	﹤0.01%	4909
2018 Q1	$0	Sell	1 -11	-92%	-$8.26K	﹤0.01%	5678
2017 Q4	$4K	Buy	12 +5	+71%	+$1.91K	﹤0.01%	4882
2017 Q3	$2K	Buy	7 +4	+133%	+$1.52K	﹤0.01%	4804
2017 Q2	$1K	Buy	3 +2	+200%	+$1.51K	﹤0.01%	4884
2017 Q1	$0	Hold	1	–	–	﹤0.01%	5175
2016 Q4	$0	Sell	1 -140	-99%	-$55.8K	﹤0.01%	5138
2016 Q3	$57K	Buy	141 +16	+13%	+$7.15K	﹤0.01%	4166
2016 Q2	$61K	Buy	125 +100	+400%	+$50.8K	﹤0.01%	4326
2016 Q1	$12K	Buy	+25	New	+$14K	﹤0.01%	4787

Other funds holding HTGM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Deutsche Bank's HTGM Position: Q4 2019 in Review

Deutsche Bank sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2019, closing a stake of 99 shares — an estimated $11K sold.

Deutsche Bank first reported a position in HTGM in Q1 2016 and held it in 12 quarters. The position peaked at $61K in Q2 2016. 27 funds tracked by Wall St. Rank hold HTGM as of Q4 2019.

Deutsche Bank reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Deutsche Bank sold 99 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2019, an estimated $11K.
Deutsche Bank first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2016 and held it in 12 quarters.
Deutsche Bank's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $61K in Q2 2016.
27 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.